Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma

Fig. 4

The genomic characteristics of PVT1 expression. (A-B) differential somatic mutations were detected by comparing gliomas with low and high PVT1 expression. (C) the overall CNVs profile in order of increasing PVT1 expression. (D) the CNVs alterations in low and high PVT1 expression groups. Chromosomal locations of peaks of significantly recurring focal amplification (red) and deletions (blue) were presented

Back to article page